Back to Search Start Over

Hemorrhagic transformation after stroke: inter‐ and intrarater agreement

Authors :
Adrien Guenego
Adrien Wang
P. Koskas
Mylène Hamdani
M. Ben Maacha
Julien Duplantier
Kevin Premat
Naim Khoury
Candice Sabben
Gabriele Ciccio
Jean Raymond
Stanislas Smajda
Benjamin Maïer
Adrien Collin
Jean-Marc Olivot
Sidney Krystal
Raphaël Blanc
Aspiration versus STEnt-Retriever (Aster) trial investigators
Célina Ducroux
Daniele Botta
H Redjem
Kevin Zuber
Margaux Roques
V Davy
L Di Meglio
Augustin Lecler
William Boisseau
Michel Piotin
Robert Fahed
Fondation Ophtalmologique Adolphe de Rotschild
Department of Neurology and Neurosurgery [Montreal]
Montreal Neurological Institute and Hospital
McGill University = Université McGill [Montréal, Canada]-McGill University = Université McGill [Montréal, Canada]
University of Illinois [Springfield]
Source :
European Journal of Neurology, European Journal of Neurology, Wiley, 2018, 26 (3), pp.476-482. ⟨10.1111/ene.13859⟩
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

Background and purpose Hemorrhagic transformation (HT) is a complication of stroke that can occur spontaneously or after treatment. We aimed to assess the inter- and intrarater reliability of HT diagnosis. Methods Studies assessing the reliability of the European Cooperative Acute Stroke Study (ECASS) classification of HT or of the presence (yes/no) of HT were systematically reviewed. A total of 18 raters independently examined 30 post-thrombectomy computed tomography scans selected from the Aspiration versus STEnt-Retriever (ASTER) trial. They were asked whether there was HT (yes/no), what the ECASS classification of the particular scan (0/HI1/HI2/PH1/PH2) (HI indicates hemorrhagic infarctions and PH indicates parenchymal hematomas) was and whether they would prescribe an antiplatelet agent if it was otherwise indicated. Agreement was measured with Fleiss' and Cohen's κ statistics. Results The systematic review yielded four studies involving few (≤3) raters with heterogeneous results. In our 18-rater study, agreement for the presence of HT was moderate [κ = 0.55; 95% confidence interval (CI), 0.41-0.68]. Agreement for ECASS classification was only fair for all five categories, but agreement improved to substantial (κ = 0.72; 95% CI, 0.69-0.75) after dichotomizing the ECASS classification into 0/HI1/HI2/PH1 versus PH2. The inter-rater agreement for the decision to reintroduce antiplatelet therapy was moderate for all raters, but substantial among vascular neurologists (κ = 0.70; 95% CI, 0.57-0.84). Conclusion The ECASS classification may involve too many categories and the diagnosis of HT may not be easily replicable, except in the presence of a large parenchymal hematoma.

Details

Language :
English
ISSN :
13515101 and 14681331
Database :
OpenAIRE
Journal :
European Journal of Neurology, European Journal of Neurology, Wiley, 2018, 26 (3), pp.476-482. ⟨10.1111/ene.13859⟩
Accession number :
edsair.doi.dedup.....740870d7ccfd9ddf80b261e074f18d3e
Full Text :
https://doi.org/10.1111/ene.13859⟩